Cutaneous lupus mucinosis: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Cutaneous lupus mucinosis | |||
| image = <!-- Image removed --> | |||
| caption = <!-- Caption removed --> | |||
| field = [[Dermatology]] | |||
| synonyms = Lupus erythematosus tumidus | |||
}} | |||
'''Cutaneous lupus mucinosis''' is a rare [[skin condition]] characterized by the accumulation of [[mucin]] in the [[dermis]]. It is considered a variant of [[lupus erythematosus]], specifically associated with [[cutaneous lupus erythematosus]]. | |||
Cutaneous | |||
== | ==Presentation== | ||
Patients with cutaneous lupus mucinosis typically present with [[erythematous]] or [[skin-colored]] papules and plaques. These lesions are often found on sun-exposed areas of the skin, such as the [[face]], [[neck]], and [[arms]]. The condition may be associated with [[pruritus]] (itching) and can lead to [[cosmetic]] concerns due to its appearance. | |||
==Pathophysiology== | |||
The exact cause of cutaneous lupus mucinosis is not well understood, but it is believed to involve an [[autoimmune]] process. The accumulation of mucin in the skin is thought to result from [[inflammation]] and [[immune system]] activity characteristic of lupus erythematosus. Mucin is a [[glycoprotein]] that contributes to the [[gel-like]] consistency of the [[extracellular matrix]]. | |||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of | Diagnosis of cutaneous lupus mucinosis is typically made through a combination of [[clinical examination]] and [[skin biopsy]]. Histological examination of the biopsy will reveal increased mucin deposition in the dermis, along with other features consistent with lupus erythematosus. | ||
==Treatment== | ==Treatment== | ||
Treatment for | Treatment options for cutaneous lupus mucinosis may include topical and systemic [[corticosteroids]], [[antimalarial drugs]] such as [[hydroxychloroquine]], and other immunosuppressive agents. Sun protection is also recommended to prevent exacerbation of the condition. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for | The prognosis for cutaneous lupus mucinosis varies. Some patients may experience spontaneous resolution of lesions, while others may have a chronic course requiring ongoing management. The condition is generally not life-threatening but can significantly impact [[quality of life]]. | ||
==See also== | |||
* [[Lupus erythematosus]] | |||
* [[Cutaneous lupus erythematosus]] | |||
* [[Mucin]] | |||
==References== | |||
{{Reflist}} | |||
==External links== | |||
* [https://www.wikimd.com/wiki/Cutaneous_lupus_mucinosis Cutaneous lupus mucinosis on WikiMD] | |||
[[Category: | [[Category:Dermatology]] | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category: | [[Category:Connective tissue diseases]] | ||
Latest revision as of 21:16, 27 December 2024
| Cutaneous lupus mucinosis | |
|---|---|
| Synonyms | Lupus erythematosus tumidus |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | N/A |
| Complications | N/A |
| Onset | N/A |
| Duration | N/A |
| Types | N/A |
| Causes | N/A |
| Risks | N/A |
| Diagnosis | N/A |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | N/A |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | N/A |
| Deaths | N/A |
Cutaneous lupus mucinosis is a rare skin condition characterized by the accumulation of mucin in the dermis. It is considered a variant of lupus erythematosus, specifically associated with cutaneous lupus erythematosus.
Presentation[edit]
Patients with cutaneous lupus mucinosis typically present with erythematous or skin-colored papules and plaques. These lesions are often found on sun-exposed areas of the skin, such as the face, neck, and arms. The condition may be associated with pruritus (itching) and can lead to cosmetic concerns due to its appearance.
Pathophysiology[edit]
The exact cause of cutaneous lupus mucinosis is not well understood, but it is believed to involve an autoimmune process. The accumulation of mucin in the skin is thought to result from inflammation and immune system activity characteristic of lupus erythematosus. Mucin is a glycoprotein that contributes to the gel-like consistency of the extracellular matrix.
Diagnosis[edit]
Diagnosis of cutaneous lupus mucinosis is typically made through a combination of clinical examination and skin biopsy. Histological examination of the biopsy will reveal increased mucin deposition in the dermis, along with other features consistent with lupus erythematosus.
Treatment[edit]
Treatment options for cutaneous lupus mucinosis may include topical and systemic corticosteroids, antimalarial drugs such as hydroxychloroquine, and other immunosuppressive agents. Sun protection is also recommended to prevent exacerbation of the condition.
Prognosis[edit]
The prognosis for cutaneous lupus mucinosis varies. Some patients may experience spontaneous resolution of lesions, while others may have a chronic course requiring ongoing management. The condition is generally not life-threatening but can significantly impact quality of life.
See also[edit]
References[edit]
<references group="" responsive="1"></references>